search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
136 new news items in the last 24 hours
  1. Home
  2. Health

NeoVax(MI) vaccine developed by Dana-Farber Cancer Institute could be approved soon with promising results in boosting immune response in melanoma patients

Lara Maior
whatsapp
facebook
linkedin
x
copy-link copy-link
14 July 2025, 12:39
main event image
Health
Vyacheslav Lopatin / Alamy / Profimedia
google-preference

Always see our news on Google

The clinical trial of the personalized vaccine NeoVax(MI) has shown promising results in the treatment of melanoma, generating a strong immune response. The vaccine contains patient-specific neoantigens and is administered together with standard immunotherapies such as nivolumab and ipilimumab. Scientists observed an increase in immune cells after vaccination, indicating effective immune activation. This innovative approach could significantly improve treatments for skin cancer.

Sources

sursa imagine
Fanatik
Vaccinul contra unui tip agresiv de cancer, la un pas de a intra pe piață. Rezultatele remarcabile dau speranțe pacienților
sursa imagine
Economedia
Consiliul Concurenței analizează tranzacţia prin care Mehiläinen Oy preia rețeaua de centre mediale Regina Maria
sursa imagine
News.ro
Consiliul Concurenţei analizează preluarea Grupului Regina Maria de către Mehiläinen Oy

Latest News

22:43

A delivery driver from Sri Lanka attacked in Iași County. The attacker destroyed his scooter and phone

22:27

Ilie Bolojan, on the risk of the PNL splitting: “We do not expect anyone to leave the party”

22:04

Donald Trump announces good talks with Vladimir Putin and says that the Russian leader wants to end the war in Ukraine through diplomatic means

21:51

Zohran Mamdani announces the closure of the Rikers Island prison complex by 2032

21:21

EUROCONTROL blocks the sums owed to ROMATSA again / The garnishment was imposed at Pfizer’s request in the dispute concerning COVID-19 vaccines

See more news

NEWS ON THE SAME TOPICS

event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
event image
Health
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
event image
EU
The EU–Africa Partnership is providing more than €64 million to fund five networks aimed at speeding up clinical trials during epidemics
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Vaccine melanoma skin cancer innovation research oncology

Editor’s Recommendations

main event image
Current Affairs
1 hour ago

EUROCONTROL blocks the sums owed to ROMATSA again / The garnishment was imposed at Pfizer’s request in the dispute concerning COVID-19 vaccines

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
12 hours ago

EXCLUSIVE | Romania, as viewed by the Russian press / The scenario of unification with the Republic of Moldova, described as a “capitulation” of Chișinău

main event image
Opinions
6 hours ago

Andrei Cornea: Politics, Ethics and Fanaticism

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol